Skip to main content

Table 2 Maternal characteristics of the AFLP and HELLP syndrome groups

From: Comparison of maternal and neonatal outcomes between acute fatty liver of pregnancy and hemolysis, elevated liver enzymes and low platelets syndrome: a retrospective cohort study

 

AFLP

(n = 21)

HELLP syndrome

(n = 80)

P

Maternal age (years)a

33.5 ± 5.5

(31, 36)

33.7 ± 5.0

(32.5, 34.8)

0.920

Body mass index (kg/m2) at deliverya

24.4 ± 3.2

(22.7, 26)

28.7 ± 5.1

(27.5, 30)

0.001*

Gravidab

1.5 (1)

2 (2)

0.590

Parab

1 (1)

1 (1)

0.502

Nulliparac

15 (71.4)

50 (62.5)

0.447

Twin pregnancyc

6 (28.6)

4 (5.0)

0.005*

SBP on admission (mmHg)a

129.3 ± 14.6

(122.5, 136.1)

159.2 ± 21.5

(154.4, 164)

< 0.001*

DBP on admission (mmHg)a

75.1 ± 12.0

(69.5, 80.7)

96.4 ± 16.0

(92.9, 100)

< 0.001*

Chronic hypertensionc

0 (0)

1 (1.3)

> 0.99

Gestational hypertensionc

0 (0)

0 (0)

> 0.99

Delivery age (weeks)b

34.6 (3.4)

(33, 36.3)

33.9 (6.9)

(32.1, 34.9)

0.137

Cesarean deliveryc

19 (90.5)

68 (85.0)

> 0.99

  1. AFLP acute fatty liver of pregnancy; HELLP hemolysis, elevated liver enzymes and low platelets; SBP systolic blood pressure; DBP diastolic blood pressure
  2. aStudent’s t test, results are presented as mean ± standard deviation, (95 % confidence interval)
  3. bMann-Whitney U test, results are presented as median (interquartile range), (95 % confidence interval)
  4. cChi-square or Fisher’s exact test, results are presented as number (percentage)
  5. *P < 0.05 was considered to be statistically significant